(19)
(11) EP 1 848 403 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.05.2010 Bulletin 2010/20

(45) Mention of the grant of the patent:
31.03.2010 Bulletin 2010/13

(21) Application number: 05818337.7

(22) Date of filing: 09.12.2005
(51) International Patent Classification (IPC): 
A61K 9/10(2006.01)
A61K 9/12(2006.01)
 A61K 9/06(2006.01)
(86) International application number:
PCT/GB2005/004746
(87) International publication number:
WO 2006/075123 (20.07.2006 Gazette 2006/29)

(54)

TOPICAL BIOADHESIVE FORMULATIONS

TOPISCHE BIOADHÄSIVE FORMULIERUNGEN

FORMULATIONS BIOADHESIVES TOPIQUES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 14.01.2005 GB 0500807
18.04.2005 GB 0507811
06.06.2005 WO PCT/GB2005/002217

(43) Date of publication of application:
31.10.2007 Bulletin 2007/44

(60) Divisional application:
09014796.8

(73) Proprietor: CAMURUS AB
223 70 Lund (SE)

(72) Inventors:
  • JOABSSON, Fredrik
    S-223 70 Lund (SE)
  • LINDEN, Margareta
    S-223 70 Lund (SE)
  • THURESSON, Krister
    S-223 70 Lund (SE)
  • TIBERG, Fredrik
    S-223 70 Lund (SE)

(74) Representative: Goddard, Christopher Robert 
Dehns St Bride's House 10 Salisbury Square
London EC4Y 8JD
London EC4Y 8JD (GB)


(56) References cited: : 
WO-A-97/13528
WO-A-02/068562
US-A- 5 807 573
 WO-A-98/47487
WO-A-2005/046642
US-B1- 6 464 987
   
  • SHAH JAYMIN C ET AL: "Cubic phase gels as drug delivery systems" ADVANCED DRUG DELIVERY REVIEWS, AMSTERDAM, NL, vol. 47, no. 2-3, 25 April 2001 (2001-04-25), pages 229-250, XP002320651 ISSN: 0169-409X
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).